These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28988945)

  • 21. Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications.
    Simó R; Hernández C;
    Br J Ophthalmol; 2012 Oct; 96(10):1285-90. PubMed ID: 22887976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications.
    Stem MS; Gardner TW
    Curr Med Chem; 2013; 20(26):3241-50. PubMed ID: 23745549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal Neurodegeneration in Diabetes: an Emerging Concept in Diabetic Retinopathy.
    Sachdeva MM
    Curr Diab Rep; 2021 Dec; 21(12):65. PubMed ID: 34902066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients.
    Mrugacz M; Bryl A; Bossowski A
    Curr Neuropharmacol; 2016; 14(8):826-830. PubMed ID: 27212050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal Neurodegeneration Associated With Peripheral Nerve Conduction and Autonomic Nerve Function in Diabetic Patients.
    Kim K; Yu SY; Kwak HW; Kim ES
    Am J Ophthalmol; 2016 Oct; 170():15-24. PubMed ID: 27381712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in Macular Retinal Layers and Peripapillary Nerve Fiber Layer Thickness after 577-nm Pattern Scanning Laser in Patients with Diabetic Retinopathy.
    Shin JS; Lee YH
    Korean J Ophthalmol; 2017 Dec; 31(6):497-507. PubMed ID: 29022292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular Changes and Neurodegeneration in the Early Stages of Diabetic Retinopathy: Which Comes First?
    Jonsson KB; Frydkjaer-Olsen U; Grauslund J
    Ophthalmic Res; 2016; 56(1):1-9. PubMed ID: 27035578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases.
    Cuenca N; Fernández-Sánchez L; Campello L; Maneu V; De la Villa P; Lax P; Pinilla I
    Prog Retin Eye Res; 2014 Nov; 43():17-75. PubMed ID: 25038518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disorganized retinal lamellar structures in nonperfused areas of diabetic retinopathy.
    Dodo Y; Murakami T; Uji A; Yoshitake S; Yoshimura N
    Invest Ophthalmol Vis Sci; 2015 Mar; 56(3):2012-20. PubMed ID: 25736792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RETINAL MORPHOMETRY CHANGES MEASURED WITH SPECTRAL DOMAIN-OPTICAL COHERENCE TOMOGRAPHY AFTER PAN-RETINAL PHOTOCOAGULATION IN PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY.
    Mitsch C; Pemp B; Kriechbaum K; Bolz M; Scholda C; Schmidt-Erfurth U
    Retina; 2016 Jun; 36(6):1162-9. PubMed ID: 26562565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The state of ocular neurosensory apparatus in diabetes mellitus].
    Sdobnikova SV; Kulybysheva VS; Sidamonidze AL
    Vestn Oftalmol; 2018; 134(5. Vyp. 2):263-269. PubMed ID: 30499527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effects of cilostazol on retinal ganglion cell damage in diabetic rats.
    Jung KI; Kim JH; Park HY; Park CK
    J Pharmacol Exp Ther; 2013 Jun; 345(3):457-63. PubMed ID: 23536314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurodegeneration as a primary change and role of neuroprotection in diabetic retinopathy.
    Jindal V
    Mol Neurobiol; 2015; 51(3):878-84. PubMed ID: 24826918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macular morphology in patients with optic nerve head drusen and optic disc edema.
    Pilat AV; Proudlock FA; Kumar P; Lee H; Papageorgiou E; Gottlob I
    Ophthalmology; 2014 Feb; 121(2):552-7. PubMed ID: 24238882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between spectral domain optical coherence tomography findings and fluorescein angiography patterns in diabetic macular edema.
    Yeung L; Lima VC; Garcia P; Landa G; Rosen RB
    Ophthalmology; 2009 Jun; 116(6):1158-67. PubMed ID: 19395034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single Retinal Layer Evaluation in Patients with Type 1 Diabetes with No or Early Signs of Diabetic Retinopathy: The First Hint of Neurovascular Crosstalk Damage between Neurons and Capillaries?
    Scarinci F; Picconi F; Virgili G; Giorno P; Di Renzo A; Varano M; Frontoni S; Parravano M
    Ophthalmologica; 2017; 237(4):223-231. PubMed ID: 28391270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between retinal neuronal degeneration and visual function impairment in type 2 diabetic patients without diabetic retinopathy.
    Zhu T; Ma J; Li Y; Zhang Z
    Sci China Life Sci; 2015 Jun; 58(6):550-5. PubMed ID: 25951931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinal architecture recovery after grid photocoagulation in diabetic macular edema observed in vivo by spectral domain optical coherence tomography.
    Mylonas G; Bolz M; Kriechbaum K; Treu C; Deak G; Lammer J; Scholda C; Schmidt-Erfurth U
    Retina; 2013 Apr; 33(4):717-25. PubMed ID: 23528703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotection in diabetic retinopathy.
    Hernández C; Simó R
    Curr Diab Rep; 2012 Aug; 12(4):329-37. PubMed ID: 22581259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.